With health care reform on the horizon, the business case for quality and efficiency in health care has never been clearer. The new system will encourage payers to reimburse only for consistent and efficient care. Increasing transparency will make it easier for patients, who will in turn demand care that meets their needs. Preparing for the future of health care is therefore critical to the survival of many organizations. This changing health care landscape will have implications for medical providers and suppliers alike.
This session provides an overview of health care reform by understanding Massachusetts reform as a likely model. Dr. John Freedman outlines how such changes are likely to impact clinicians, as well as medical suppliers. This includes outlining key macro trends related to performance measurement, improvement, efficiency and cost containment.
Cost & Effectiveness: Healthcare Reform and its Implications for Pharma & Devices is being presented by Dr. John Freedman, Principal, of Freedman HealthCare, LLC and airs on Thursday, December 3, 2009. For more details or to register, please visit our site at www.fxconferences.com
